Today: 9 June 2026
Lumentum stock price whipsaws 9% as traders brace for Feb. 3 earnings
30 January 2026
1 min read

Lumentum stock price whipsaws 9% as traders brace for Feb. 3 earnings

New York, January 29, 2026, 21:33 EST — Market closed.

  • Lumentum shares fell 0.9% to $381.44 after swinging between $364.19 and $398.16
  • The company set a March 17 investor briefing at OFC 2026 in Los Angeles
  • Investors are positioning for Lumentum’s Feb. 3 quarterly results and outlook

Lumentum Holdings Inc (LITE) shares swung more than 9% on Thursday before closing down 0.9% at $381.44, a choppy finish that kept the stock in play heading into next week’s earnings report.

The timing matters. Investors are re-pricing parts of the AI trade after a bruising day for U.S. tech, and suppliers tied to data-center buildouts are being pulled into that push and pull.

Lumentum added its own checkpoint on Wednesday, saying management will host an investor briefing during the Optical Fiber Communication Conference and Exhibition in Los Angeles on March 17.

The wider tape was not friendly. The Nasdaq slid 0.7% and technology was the weakest of the major S&P sectors as Microsoft sank 10%, reviving doubts about whether soaring AI budgets will pay off quickly. “Microsoft disappointed and there are some genuine concerns that AI investments will eat the software companies’ lunches,” John Praveen, managing director and co-CIO at Paleo Leon, said. Reuters

Lumentum, headquartered in San Jose, makes optical and photonic products used in telecom, enterprise and data-center networks, along with lasers used in manufacturing and sensing applications.

Some investors treat the stock as a read-through on demand for high-speed optical links inside data centers, where buildouts can come in bursts and then pause.

The near-term catalyst is Feb. 3. Lumentum is scheduled to release fiscal second-quarter results after the market closes and host a webcast at 5 p.m. ET, the company said in an earlier notice.

Besides the headline numbers, traders will be listening for guidance that speaks to order timing and customer spending patterns, and for any signs that supply and pricing are tightening in its optical components.

But sentiment can flip fast when investors start debating whether AI is creating winners or just reshuffling budgets. “The market’s kind of in our view pricing a worst-case scenario that software is dead because AI is disrupting the space,” Adam Turnquist, chief technical strategist for LPL Financial, told Reuters. Reuters

For Lumentum, any hint that customers are stretching deployments or smoothing orders could hit the stock, especially after a session like Thursday.

Into Friday, traders will watch whether Lumentum can stay anchored after Thursday’s $364-to-$398 swing. Next week, the focus tightens to Feb. 3 — and then to what management chooses to put on the table at OFC in March.

Stock Market Today

  • Constant and Constant Advises Piraeus Bank on Safe Bulkers Euronext Athens Dual Listing
    June 9, 2026, 9:51 AM EDT. Constant and Constant Greece and UK firm TLT advised Piraeus Bank on the dual listing of Safe Bulkers, Inc. on Euronext Athens, marking the first Greek shipping company listed in New York to also trade on Athens' exchange. Safe Bulkers, a marine dry bulk carrier with 45 vessels, is now accessible to both U.S. and Greek investors. The legal teams led cross-border due diligence covering loan facilities, guarantees, and fleet agreements to ensure compliance. This move is expected to pave the way for similar listings, enhancing Greece's capital markets. Safe Bulkers' CFO praised the firms for precise, detailed legal support throughout the complex process.

Latest articles

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

9 June 2026
Regentis Biomaterials shares dipped 2 cents to $1.28 premarket after the company announced European surgeon training for its GelrinC knee implant will begin in Q3, marking a key commercial step but leaving investors waiting for revenue proof as the stock trades far below its $8 IPO price.
IREN Stock Approaches $60 as AI Data-Center Bet Hits Key Point

IREN Stock Approaches $60 as AI Data-Center Bet Hits Key Point

9 June 2026
IREN surged 8.9% to $59.19 and was quoted higher premarket after a bitcoin rebound and renewed focus on its pivot to AI cloud infrastructure, but the stock remains exposed to bitcoin swings, heavy spending, and risks tied to its new 800MW South Australia data center project and major contracts with Nvidia and Microsoft.
AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

9 June 2026
AT&T shares edged up to $22.58 pre-market after reaffirming 2026 guidance and a $45B+ shareholder return plan, providing a cash-flow marker as satellite broadband competition looms; the stock remains pressured by SpaceX risks flagged by Oppenheimer, with second-quarter free cash flow seen at $4.0–$4.5B.
GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

9 June 2026
GSK will buy Nuvalent for $10.6 billion in cash, paying a 40% premium, to boost its oncology pipeline ahead of looming HIV drug patent expiries; Nuvalent shares jumped 38.9% premarket while GSK fell 1.4%, with the deal expected to add to GSK sales and profit from 2027 but dilute earnings per share 2026-2028 if it closes in Q3, and final outcome depends on FDA approvals and regulatory clearance.
Accenture stock slides 3% as new share award pool wins approval — what investors watch next
Previous Story

Accenture stock slides 3% as new share award pool wins approval — what investors watch next

GSK share price dips in London as Exdensur rollout and Feb 4 results loom
Next Story

GSK share price dips in London as Exdensur rollout and Feb 4 results loom

Go toTop